MAIA Chart
See on advanced chart >
About
MAIA Biotechnology, Inc. was incorporated in the state of Delaware on August 3, 2018. The company is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO, their lead asset, is an investigational dual mechanism of...
Read More
- HighlightA clinical stage biotechnology company that developing therapies for non-small cell lung cancer
- ExchangeAMEX
- Listing Date07/28/2022
- Established Date08/03/2018
- Full-time Employees18
- Address444 West Lake Street Suite 1700 Chicago IL 60606
- Tel1-312-4168592
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Pharmaceuticals
